Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 17/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 11/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 11/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.70 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.70 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.70 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.69 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.69 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.59 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2566503 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL30485092 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL7478959 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL1824105 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL7537507 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL18717940 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL10597737 | 1.00 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL29357899 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL28847757 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 | |
| SCHEMBL28847754 | 0.93 | CYP3A4 (0.63) | CYP3A4CYP2C9CYP2C19LMNACYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3564207-B1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | KANEKA CORP (JP) | 2021-09-15 | — | — | EP | claimed |
| US-10919829-B2 | Method for producing alcohol compound | KANEKA CORPORATION (JP) | 2021-02-16 | — | — | US | claimed |
| EP-3564207-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | Kaneka Corporation (JP) | 2019-11-06 | — | — | EP | claimed |
| US-20190300465-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | KANEKA CORPORATION (JP) | 2019-10-03 | — | — | US | claimed |
| US-12018010-B2 | Method for preparing efinaconazole using ionic liquid as medium | DAEBONG LS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-12018010-B2 | Method for preparing efinaconazole using ionic liquid as medium | DAEBONG LS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-12018010-B2 | Method for preparing efinaconazole using ionic liquid as medium | DAEBONG LS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| EP-3915981-B1 | METHOD FOR PREPARATION OF EFINACONAZOLE IN IONIC LIQUID MEDIUM | DAEBONG LS CO LTD (KR) | 2024-04-03 | — | — | EP | disclosed |
| US-20220127245-A1 | METHOD FOR PREPARATION OF EFINACONAZOLE IN IONIC LIQUID MEDIUM | DAEBONG LS CO., LTD. (KR) | 2022-04-28 | — | — | US | disclosed |
| EP-3666762-B1 | METHOD FOR PRODUCING EPOXY ALCOHOL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2022-04-06 | — | — | EP | disclosed |
| EP-3915981-A1 | METHOD FOR PREPARATION OF EFINACONAZOLE IN IONIC LIQUID MEDIUM | Daebong LS Co., Ltd. (KR) | 2021-12-01 | — | — | EP | disclosed |
| EP-3564207-B1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | KANEKA CORP (JP) | 2021-09-15 | — | — | EP | disclosed |
| US-6133485-A | Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols | SYNPHAR LABORATORIES, INC. (CA) | 2000-10-17 | — | — | US | disclosed |
| WO-1999052840-A1 | ASYMMETRIC SYNTHESIS OF 2-ARYL-1-SUBSTITUTED BUTAN-2,3-DIOLS | NAEJA PHARMACEUTICAL INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| EP-0728752-A1 | Triazole compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-28 | — | — | EP | disclosed |
| EP-0659751-A1 | Optically active azole derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-06-28 | — | — | EP | disclosed |
| US-5405861-A | Fungicides | TAKEDA CHEMICAL INDUSTRIES, CO., LTD. (JP) | 1995-04-11 | — | — | US | disclosed |
| US-5387599-A | Fungicide | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-02-07 | — | — | US | disclosed |
| EP-0446877-A2 | Triazoles, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-09-18 | — | — | EP | disclosed |
| EP-0421210-A2 | Triazole compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018010-B2 | Method for preparing efinaconazole using ionic liquid as medium | CYP3A5, CYP3A7, NEFM | CYP3A4 4/4885CYP2C9 20/4885CYP2C19 15/4885 |
| US-20220127245-A1 | METHOD FOR PREPARATION OF EFINACONAZOLE IN IONIC LIQUID MEDIUM | CYP3A5, NEFM, IL5 | CYP3A4 5/4885CYP2C9 24/4885CYP2C19 17/4885 |
| US-10919829-B2 | Method for producing alcohol compound | ADH1A, ADH1C, MEP1B | CYP3A4 758/4885CYP2C9 1512/4885CYP2C19 1658/4885 |
| US-20190300465-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | ADH1A, ADH1C, MEP1B | CYP3A4 758/4885CYP2C9 1512/4885CYP2C19 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.